jRCT1032260031招募中不适用
An open-label, randomized controlled study of the manufacturing efficiency and clinical performance of digital radiotherapy prostheses for patients undergoing brachytherapy for tongue cancer
未提供0 个研究点目标入组 10 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 20age old over 至 No limit(—)
- 性别
- All
入选标准
- •Tongue cancer patients scheduled for brachytherapy (regardless of primary or recurrent disease)
- •Patients having stable occlusion with at least one occlusal unit on each side supported by residual teeth, totaling three or more occlusal units
- •Patients with sufficient space (at least 10mm) between the treatment area and mandible for prostheses placement
- •Patients with a maximum mouth opening of 30mm or greater
- •Patients aged 20 years or older at the time of consent acquisition
- •Patients who have provided written informed consent to participate in this clinical study
排除标准
- •Patients with mobile teeth preventing impression taking using impression materials
- •Patients requiring urgent treatment for whom the necessary laboratory processing time cannot be secured
- •Patients with significant oral pain that interferes with impression taking
- •Patients with a history of hypersensitivity to the dental materials used
- •Patients with communication difficulties due to cognitive impairment or other conditions
- •Other patients deemed unsuitable for participation in this study by the principal investigator (or co-investigator)
研究者
相似试验
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
4 期
An open-label, randomized, single-dose, two-period, two-treatment, crossover bioequivalence study with GP-IMP-001 in healthy male volunteers under fasting conditions.2025-522921-37-00Gebro Pharma GmbH36
招募中
4 期
An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared with Nicorette® lozenge 4 mg in healthy adults who use cigarettes2025-523879-34-00Swedish Match North Europe AB72
招募中
1 期
A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications2023-506227-29-00AbbVie Deutschland GmbH & Co. KG60
招募中
1 期
A Phase 1b, Randomized, Open-Label Trial to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB097 in Combination with Pembrolizumab in Melanoma Patients with Primary Resistance to an Anti-PD-1-Containing Immunotherapy (MELODY-1)Advanced Melanoma2023-507377-17-00Microbiotica Limited27
